Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Antigen-dependent interactions between regulatory B cells and T cells at the T:B border inhibit subsequent T cell interactions with DCs.

Mohib K, Cherukuri A, Zhou Y, Ding Q, Watkins SC, Rothstein DM.

Am J Transplant. 2019 Jul 29. doi: 10.1111/ajt.15546. [Epub ahead of print]

PMID:
31355483
2.

C-Type Natriuretic Peptide Analogue Therapy in Children with Achondroplasia.

Savarirayan R, Irving M, Bacino CA, Bostwick B, Charrow J, Cormier-Daire V, Le Quan Sang KH, Dickson P, Harmatz P, Phillips J, Owen N, Cherukuri A, Jayaram K, Jeha GS, Larimore K, Chan ML, Huntsman Labed A, Day J, Hoover-Fong J.

N Engl J Med. 2019 Jul 4;381(1):25-35. doi: 10.1056/NEJMoa1813446. Epub 2019 Jun 18.

PMID:
31269546
3.

Toward a Clinical Point of Care Tool for Managing Heart Failure.

Chen Z, Cherukuri A, Das SR, Amin A, Tamil LS, Gupta G.

AMIA Jt Summits Transl Sci Proc. 2019 May 6;2019:819-828. eCollection 2019.

4.

Post-transplant donor specific antibody is associated with poor kidney transplant outcomes only when combined with both T-cell-mediated rejection and non-adherence.

Cherukuri A, Mehta R, Sharma A, Sood P, Zeevi A, Tevar AD, Rothstein DM, Hariharan S.

Kidney Int. 2019 Jul;96(1):202-213. doi: 10.1016/j.kint.2019.01.033. Epub 2019 Mar 20.

PMID:
31029504
5.

High Calcineurin Inhibitor Intrapatient Variability Is Associated With Renal Allograft Inflammation, Chronicity, and Graft Loss.

Sharma A, Cherukuri A, Mehta RB, Sood P, Hariharan S.

Transplant Direct. 2019 Jan 28;5(2):e424. doi: 10.1097/TXD.0000000000000862. eCollection 2019 Feb.

6.

Regulatory and Effector B Cells: A New Path Toward Biomarkers and Therapeutic Targets to Improve Transplant Outcomes?

Cherukuri A, Ding Q, Sharma A, Mohib K, Rothstein DM.

Clin Lab Med. 2019 Mar;39(1):15-29. doi: 10.1016/j.cll.2018.10.011. Epub 2018 Dec 18. Review.

PMID:
30709503
7.

Immunogenicity to cerliponase alfa intracerebroventricular enzyme replacement therapy for CLN2 disease: Results from a Phase 1/2 study.

Cherukuri A, Cahan H, de Hart G, Van Tuyl A, Slasor P, Bray L, Henshaw J, Ajayi T, Jacoby D, O'Neill CA, Schweighardt B.

Clin Immunol. 2018 Dec;197:68-76. doi: 10.1016/j.clim.2018.09.003. Epub 2018 Sep 8.

PMID:
30205177
8.

Shake No Bake: A Homemade Ultrasound Gel Recipe for Low-Resource Settings.

Cherukuri AR, Lane L, Guy D, Perusse K, Keating DP, DeStigter KK.

J Ultrasound Med. 2019 Apr;38(4):1069-1073. doi: 10.1002/jum.14788. Epub 2018 Sep 9.

PMID:
30196569
9.

Regulatory B cells and transplantation: almost prime time?

Mohib K, Cherukuri A, Rothstein DM.

Curr Opin Organ Transplant. 2018 Oct;23(5):524-532. doi: 10.1097/MOT.0000000000000559. Review.

PMID:
30045092
10.

Tissue sampling in the era of precision medicine: comparison of percutaneous biopsies performed for clinical trials or tumor genomics versus routine clinical care.

Cherukuri AR, Lubner MG, Zea R, Hinshaw JL, Lubner SJ, Matkowskyj KA, Foltz ML, Pickhardt PJ.

Abdom Radiol (NY). 2019 Jun;44(6):2074-2080. doi: 10.1007/s00261-018-1702-1.

PMID:
30032384
11.
12.

Small bowel obstruction and the gastrografin challenge.

D'Agostino R, Ali NS, Leshchinskiy S, Cherukuri AR, Tam JK.

Abdom Radiol (NY). 2018 Nov;43(11):2945-2954. doi: 10.1007/s00261-018-1591-3. Review.

PMID:
29632988
13.

Short-term adverse effects of early subclinical allograft inflammation in kidney transplant recipients with a rapid steroid withdrawal protocol.

Mehta R, Bhusal S, Randhawa P, Sood P, Cherukuri A, Wu C, Puttarajappa C, Hoffman W, Shah N, Mangiola M, Zeevi A, Tevar AD, Hariharan S.

Am J Transplant. 2018 Jul;18(7):1710-1717. doi: 10.1111/ajt.14627. Epub 2018 Jan 17.

14.

Mantle Cell Lymphoma Presenting as a Subcutaneous Soft Tissue Mass With an Unusual Appearance.

Cherukuri AR, Kalia V, Sturtevant NV, DeStigter KK.

Ultrasound Q. 2017 Mar;33(1):101-102. doi: 10.1097/RUQ.0000000000000265. No abstract available.

PMID:
28081018
15.

Reduced human transitional B cell T1/T2 ratio is associated with subsequent deterioration in renal allograft function.

Cherukuri A, Salama AD, Carter CR, Landsittel D, Arumugakani G, Clark B, Rothstein DM, Baker RJ.

Kidney Int. 2017 Jan;91(1):183-195. doi: 10.1016/j.kint.2016.08.028. Epub 2016 Oct 28.

PMID:
28029430
16.

Proinflammatory cytokines decrease the expression of genes critical for RPE function.

Kutty RK, Samuel W, Boyce K, Cherukuri A, Duncan T, Jaworski C, Nagineni CN, Redmond TM.

Mol Vis. 2016 Oct 8;22:1156-1168. eCollection 2016.

17.

Inflammatory cytokines regulate secretion of VEGF and chemokines by human conjunctival fibroblasts: Role in dysfunctional tear syndrome.

Nagineni CN, William A, Cherukuri A, Samuel W, Hooks JJ, Detrick B.

Cytokine. 2016 Feb;78:16-9. doi: 10.1016/j.cyto.2015.11.016. Epub 2015 Nov 23.

PMID:
26615568
18.

Resveratrol attenuates CXCL11 expression induced by proinflammatory cytokines in retinal pigment epithelial cells.

Kutty RK, Samuel W, Abay R, Cherukuri A, Nagineni CN, Duncan T, Jaworski C, Vijayasarathy C, Redmond TM.

Cytokine. 2015 Aug;74(2):335-8. doi: 10.1016/j.cyto.2015.03.016. Epub 2015 Apr 15.

19.

Resolution of low-grade proteinuria is associated with improved outcomes after renal transplantation-a retrospective longitudinal study.

Cherukuri A, Tattersall JE, Lewington AJ, Newstead CG, Baker RJ.

Am J Transplant. 2015 Mar;15(3):741-53. doi: 10.1111/ajt.13013. Epub 2015 Feb 3.

20.

Kidney Transplant Survival: Transforming Early Post-Transplant Opportunities to Long-Term Success.

Mehta R, Cherukuri A, Sood P, Puttarajappa C, Hoffman W, Wu C, Shah N, Hariharan S.

Clin Transpl. 2015;31:227-237.

PMID:
28514584
21.

Administration of bisphosphonate (ibandronate) impedes molar tooth movement in rabbits: A radiographic assessment.

Venkataramana V, Kumar SS, Reddy BV, Cherukuri AS, Sigamani KR, Chandrasekhar G.

J Pharm Bioallied Sci. 2014 Jul;6(Suppl 1):S165-70. doi: 10.4103/0975-7406.137440.

22.

Resveratrol Suppresses Expression of VEGF by Human Retinal Pigment Epithelial Cells: Potential Nutraceutical for Age-related Macular Degeneration.

Nagineni CN, Raju R, Nagineni KK, Kommineni VK, Cherukuri A, Kutty RK, Hooks JJ, Detrick B.

Aging Dis. 2014 Apr 1;5(2):88-100. doi: 10.14366/AD.2014.050088. eCollection 2014 Apr.

23.

Immunologic human renal allograft injury associates with an altered IL-10/TNF-α expression ratio in regulatory B cells.

Cherukuri A, Rothstein DM, Clark B, Carter CR, Davison A, Hernandez-Fuentes M, Hewitt E, Salama AD, Baker RJ.

J Am Soc Nephrol. 2014 Jul;25(7):1575-85. doi: 10.1681/ASN.2013080837. Epub 2014 Mar 7.

24.

Enzyme-linked immunospot assay for detection of human respiratory syncytial virus f protein-specific gamma interferon-producing T cells.

Patton K, Aslam S, Lin J, Yu L, Lambert S, Dawes G, Esser MT, Woo J, Janetzki S, Cherukuri A.

Clin Vaccine Immunol. 2014 May;21(5):628-35. doi: 10.1128/CVI.00736-13. Epub 2014 Feb 26.

25.

Predicting 5-year risk of kidney transplant failure: a prediction instrument using data available at 1 year posttransplantation.

Shabir S, Halimi JM, Cherukuri A, Ball S, Ferro C, Lipkin G, Benavente D, Gatault P, Baker R, Kiberd B, Borrows R.

Am J Kidney Dis. 2014 Apr;63(4):643-51. doi: 10.1053/j.ajkd.2013.10.059. Epub 2013 Dec 31.

PMID:
24387794
26.

Alemtuzumab induction in renal transplantation permits safe steroid avoidance with tacrolimus monotherapy: a randomized controlled trial.

Welberry Smith MP, Cherukuri A, Newstead CG, Lewington AJ, Ahmad N, Menon K, Pollard SG, Prasad P, Tibble S, Giddings E, Baker RJ.

Transplantation. 2013 Dec 27;96(12):1082-8. doi: 10.1097/TP.0b013e3182a64db9.

PMID:
24056618
27.

Translational sciences approach to RSV vaccine development.

Kurzweil V, Tang R, Galinski M, Wang K, Zuo F, Cherukuri A, Gasser RA Jr, Malkin E, Sifakis F, Mendel DB, Esser MT.

Expert Rev Vaccines. 2013 Sep;12(9):1047-60. doi: 10.1586/14760584.2013.824706. Review.

PMID:
24053398
28.

Erythropoietin critically regulates the terminal maturation of murine and human primitive erythroblasts.

Malik J, Kim AR, Tyre KA, Cherukuri AR, Palis J.

Haematologica. 2013 Nov;98(11):1778-87. doi: 10.3324/haematol.2013.087361. Epub 2013 Jul 26.

29.

Higher rate of tissue regeneration in polyploid asexual versus diploid sexual freshwater snails.

Krois NR, Cherukuri A, Puttagunta N, Neiman M.

Biol Lett. 2013 Jul 10;9(4):20130422. doi: 10.1098/rsbl.2013.0422. Print 2013 Aug 23.

30.

Adults 65 years old and older have reduced numbers of functional memory T cells to respiratory syncytial virus fusion protein.

Cherukuri A, Patton K, Gasser RA Jr, Zuo F, Woo J, Esser MT, Tang RS.

Clin Vaccine Immunol. 2013 Feb;20(2):239-47. doi: 10.1128/CVI.00580-12. Epub 2012 Dec 12.

31.

Early BK polyomavirus (BKV) reactivation in donor kidney is a risk factor for development of BKV-associated nephropathy.

Saundh BK, Baker R, Harris M, Welberry Smith MP, Cherukuri A, Hale A.

J Infect Dis. 2013 Jan 1;207(1):137-41. doi: 10.1093/infdis/jis642. Epub 2012 Oct 24.

PMID:
23100561
32.

An adjuvanted respiratory syncytial virus fusion protein induces protection in aged BALB/c mice.

Cherukuri A, Stokes KL, Patton K, Kuo H, Sakamoto K, Lambert S, Stillman E, Moore ML, Lee S.

Immun Ageing. 2012 Oct 2;9(1):21. doi: 10.1186/1742-4933-9-21.

33.

Do defective B cells contribute to reduced Treg cells and autoimmunity in patients with Common Variable Immunodeficiency?

Carter CR, Aravind G, Smalle NL, Cole JY, Cherukuri A, Savic S, Wood PM.

Immunol Lett. 2012 Nov-Dec;148(1):39-40. doi: 10.1016/j.imlet.2012.07.005. Epub 2012 Jul 31. No abstract available.

PMID:
22874660
34.

An analysis of lymphocyte phenotype after steroid avoidance with either alemtuzumab or basiliximab induction in renal transplantation.

Cherukuri A, Salama AD, Carter C, Smalle N, McCurtin R, Hewitt EW, Hernandez-Fuentes M, Clark B, Baker RJ.

Am J Transplant. 2012 Apr;12(4):919-31. doi: 10.1111/j.1600-6143.2011.03891.x. Epub 2012 Mar 5.

35.

Vaccine-specific antibody secreting cells are a robust early marker of LAIV-induced B-cell response in ferrets.

Cherukuri A, Servat E, Woo J.

Vaccine. 2012 Jan 5;30(2):237-46. doi: 10.1016/j.vaccine.2011.11.001. Epub 2011 Nov 12.

PMID:
22080173
36.

The outcomes of critically ill patients with acute kidney injury receiving renal replacement therapy.

Lines SW, Cherukuri A, Murdoch SD, Bellamy MC, Lewington AJ.

Int J Artif Organs. 2011 Jan;34(1):2-9.

PMID:
21308666
37.

A wax barrier to simulate bone resorption for pre-clinical laboratory models of cemented total hip replacements.

Cherukuri AR, Miller MA, Race A, Izant TH, Mann KA.

J Biomech. 2010 Oct 19;43(14):2855-7. doi: 10.1016/j.jbiomech.2010.06.029.

38.

Who should have pelvic vessel imaging prior to renal transplantation?

Subesinghe M, Cherukuri A, Ecuyer C, Baker RJ.

Clin Transplant. 2011 Jan-Feb;25(1):97-103. doi: 10.1111/j.1399-0012.2010.01218.x.

PMID:
20236135
39.

The clinical significance of early proteinuria after renal transplantation.

Cherukuri A, Welberry-Smith MP, Tattersall JE, Ahmad N, Newstead CG, Lewington AJ, Baker RJ.

Transplantation. 2010 Jan 27;89(2):200-7. doi: 10.1097/TP.0b013e3181c352c5.

PMID:
20098283
40.

Analysis of risk factors for mortality of incident patients commencing dialysis in East Yorkshire, UK.

Cherukuri A, Bhandari S.

QJM. 2010 Jan;103(1):41-8. doi: 10.1093/qjmed/hcp164. Epub 2009 Dec 3.

PMID:
19959632
41.

Large-scale selective sweep among Segregation Distorter chromosomes in African populations of Drosophila melanogaster.

Presgraves DC, Gérard PR, Cherukuri A, Lyttle TW.

PLoS Genet. 2009 May;5(5):e1000463. doi: 10.1371/journal.pgen.1000463. Epub 2009 May 1.

42.

The antileukemia activity of a human anti-CD40 antagonist antibody, HCD122, on human chronic lymphocytic leukemia cells.

Luqman M, Klabunde S, Lin K, Georgakis GV, Cherukuri A, Holash J, Goldbeck C, Xu X, Kadel EE 3rd, Lee SH, Aukerman SL, Jallal B, Aziz N, Weng WK, Wierda W, O'Brien S, Younes A.

Blood. 2008 Aug 1;112(3):711-20. doi: 10.1182/blood-2007-04-084756. Epub 2008 May 22.

43.

CD21/CD19 coreceptor signaling promotes B cell survival during primary immune responses.

Barrington RA, Zhang M, Zhong X, Jonsson H, Holodick N, Cherukuri A, Pierce SK, Rothstein TL, Carroll MC.

J Immunol. 2005 Sep 1;175(5):2859-67.

44.

B cell signaling is regulated by induced palmitoylation of CD81.

Cherukuri A, Carter RH, Brooks S, Bornmann W, Finn R, Dowd CS, Pierce SK.

J Biol Chem. 2004 Jul 23;279(30):31973-82. Epub 2004 May 25.

45.

Isolation of lipid rafts from B lymphocytes.

Cherukuri A, Tzeng SJ, Gidwani A, Sohn HW, Tolar P, Snyder MD, Pierce SK.

Methods Mol Biol. 2004;271:213-24.

PMID:
15146123
46.

The tetraspanin CD81 is necessary for partitioning of coligated CD19/CD21-B cell antigen receptor complexes into signaling-active lipid rafts.

Cherukuri A, Shoham T, Sohn HW, Levy S, Brooks S, Carter R, Pierce SK.

J Immunol. 2004 Jan 1;172(1):370-80.

47.

Location is everything: lipid rafts and immune cell signaling.

Dykstra M, Cherukuri A, Sohn HW, Tzeng SJ, Pierce SK.

Annu Rev Immunol. 2003;21:457-81. Epub 2001 Dec 19. Review.

PMID:
12615889
48.

Rafts and synapses in the spatial organization of immune cell signaling receptors.

Dykstra M, Cherukuri A, Pierce SK.

J Leukoc Biol. 2001 Nov;70(5):699-707. Review.

PMID:
11698488
49.

Floating the raft hypothesis: lipid rafts play a role in immune cell activation.

Cherukuri A, Dykstra M, Pierce SK.

Immunity. 2001 Jun;14(6):657-60. Review. No abstract available.

50.

Supplemental Content

Loading ...
Support Center